顯影劑市場規模、佔有率、成長分析（按產品、類型、應用、最終用途、地區）- 產業預測，2025 年至 2032 年

2023 年全球顯影劑注射器市場規模為 19 億美元，預計將從 2024 年的 20.6 億美元成長到 2032 年的 38.6 億美元，預測期內（2025-2032 年）的複合年成長率為 8.2%。

全球顯影劑注射器市場受到心血管疾病、癌症和神經系統疾病等慢性疾病盛行率上升的顯著推動。這些疾病需要透過 CT、MRI 和血管造影術進行準確的影像診斷，從而增加了對先進顯影劑注射器的需求。老齡化人口更容易患上此類疾病，進一步推動了這項需求，導致診斷影像程序激增。因此，醫療機構正在投資創新注射器，以提高影像品質和最佳化顯影劑劑量。此外，向微創技術的轉變凸顯了對精確顯影劑輸送系統的需求，以促進有效診斷和病人安全。自動注射器和雙頭注射器等技術進步提高了影像準確性和工作流程效率，推動了市場成長和精準診斷的採用。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

顯影劑市場規模（按產品和複合年成長率） (2025-2032)

• 市場概覽
• 噴射系統
  • CT注射器系統
  • MRI注射器系統
  • 心血管/血管造影術注射器系統
• 耗材
  • 管子
  • 注射器
  • 其他

顯影劑市場規模（按類型及複合年成長率） (2025-2032)

• 市場概覽
• 單頭注射器
• 雙頭注射器
• 無針注射器

顯影劑市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概覽
• 放射學
• 介入性心臟病學
• 介入放射學

顯影劑市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概覽
• 醫院
• 診斷中心
• 門診手術中心

顯影劑市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Bayer AG（Germany）
• Medtronic plc（Ireland）
• Bracco Imaging SpA（Italy）
• Guerbet（France）
• Nemoto Kyorindo Co., Ltd.（Japan）
• Ulrich GmbH & Co. KG（Germany）
• APOLLO RT Co., Ltd.（Japan）
• Shenzhen Anke High-tech Co., Ltd.（China）
• SinoMD Technology Co., Ltd.（China）
• Vivid Medical Imaging Products Co., Ltd.（China）
• Mallinckrodt plc（Ireland）
• GE Healthcare（USA）
• Siemens Healthineers AG（Germany）
• Philips（Netherlands）
• Terumo Corporation（Japan）
• Cook Medical（USA）
• Acist Medical Systems, Inc.（USA）

結論和建議

Global Contrast Media Injectors Market size was valued at USD 1.9 billion in 2023 and is poised to grow from USD 2.06 billion in 2024 to USD 3.86 billion by 2032, growing at a CAGR of 8.2% during the forecast period (2025-2032).

The global contrast media injectors market is significantly propelled by the rising prevalence of chronic diseases, including cardiovascular diseases, cancer, and neurological disorders. These conditions necessitate accurate imaging diagnostics through CT, MRI, and angiography, increasing the demand for advanced contrast media injectors. The aging population, more vulnerable to such ailments, further fuels this demand, leading to a surge in diagnostic imaging procedures. Consequently, healthcare facilities are investing in innovative injectors that enhance image quality and optimize contrast media dosage. Additionally, the shift towards minimally invasive techniques underscores the need for precise contrast delivery systems that promote effective diagnosis and patient safety. Technological advancements, such as automated and dual-head injectors, are enhancing imaging accuracy and workflow efficiency, driving market growth and adoption of precision diagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contrast Media Injectors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contrast Media Injectors Market Segments Analysis

Global Contrast Media Injectors Market is segmented by Product, Type, Application, End Use and region. Based on Product, the market is segmented into Injector Systems, Consumables and Accessories. Based on Type, the market is segmented into Single Head Injectors, Dual-Head Injectors and Syringeless Injectors. Based on Application, the market is segmented into Radiology, Interventional Cardiology and Interventional Radiology. Based on End Use, the market is segmented into Hospitals, Diagnostic Centers and Ambulatory Surgery Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Contrast Media Injectors Market

The rising incidence of chronic illnesses, including cancer, cardiovascular diseases, and diabetes, is driving the demand for early diagnostic imaging. This heightened need for prompt diagnosis and patient monitoring encourages healthcare providers to utilize contrast media injectors more frequently. As a result, the market for these injectors is experiencing significant growth, reflecting a broader trend toward the adoption of advanced imaging technologies in healthcare settings. This shift not only facilitates better diagnosis and treatment but also underscores the importance of innovative solutions in improving patient outcomes in a landscape where timely medical intervention is crucial.

Restraints in the Global Contrast Media Injectors Market

The Global Contrast Media Injectors market faces significant challenges due to intricate regulatory frameworks governing medical devices. These regulatory processes often result in prolonged delays for product approvals and subsequently hinder timely market entry. Variations in regulations across different countries can further impede the momentum of innovation, restricting growth prospects and the integration of new technologies within the industry. Consequently, the regulatory landscape poses a substantial restraint, limiting both the advancement of novel contrast media injectors and the overall expansion of the market as a whole. Addressing these regulatory hurdles is crucial for fostering growth and innovation in this sector.

Market Trends of the Global Contrast Media Injectors Market

The Global Contrast Media Injectors market is witnessing a significant transformation driven by the integration of Artificial Intelligence (AI), which enhances precision, efficiency, and patient safety in diagnostic imaging. AI-powered systems utilize real-time analytics to tailor contrast dosing to individual patient characteristics, effectively reducing the incidence of contrast-induced nephropathy while improving image quality essential for accurate diagnoses. Automation capabilities in these injectors further minimize human errors and reduce contrast wastage, optimizing workflows within radiology departments. Prominent innovations, like Bayer's AI-integrated MEDRAD(R) Centargo CT Injection System, exemplify the trend toward enhanced operational efficiency, predictive analytics, and personalized imaging strategies, contributing to an expanding market landscape as healthcare increasingly embraces AI technologies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Contrast Media Injectors Market Size by Product & CAGR (2025-2032)

• Market Overview
• Injector Systems
  • CT injector systems
  • MRI injector systems
  • Cardiovascular/angiography injector systems
• Consumables
  • Tubing
  • Syringe
  • Others

Global Contrast Media Injectors Market Size by Type & CAGR (2025-2032)

• Market Overview
• Single Head Injectors
• Dual-Head Injectors
• Syringeless Injectors

Global Contrast Media Injectors Market Size by Application & CAGR (2025-2032)

• Market Overview
• Radiology
• Interventional Cardiology
• Interventional Radiology

Global Contrast Media Injectors Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers

Global Contrast Media Injectors Market Size & CAGR (2025-2032)

• North America (Product, Type, Application, End Use)
  • US
  • Canada
• Europe (Product, Type, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guerbet (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nemoto Kyorindo Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ulrich GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• APOLLO RT Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Anke High-tech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SinoMD Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivid Medical Imaging Products Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acist Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations